Dosing Retatrutide is administered once a week, similar to Ozempic
Regular thyroid function tests under the supervision of a healthcare professional are recommended
Among firms offering health benefits, 16% believe that their employees level of concern over the affordability of cost sharing is high, 29% believe the level of concern is moderate, 28% believe the level of concern is low, 20% believe the level of concern is none, and 7% do not know the level of concern [Figure 13.22]
The yearly cost ranges between $80,000 to $110,000 (Jiao et al., 2021
Effect of liraglutide treatment on prediabetes and overweight or obesity in Clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial
Liraglutide, semaglutide and tirzepatide are incretin-based therapies currently approved by FDA for the management of obesity, while triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), the cagrilintide/semaglutide (CagriSema) 2.4 mg combination, high-dose oral semaglutide, and oral orforglipron are in advanced stages of development